Study

Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. – Cost Effective Supplements

Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/8880292


Conclusion of this study

Urine glucose levels showed similar trend. Mean total cholesterol levels showed mild reduction during basil treatment period. The findings from this study suggest that basil leaves may be prescribed as adjunct to dietary therapy and drug treatment in mild to moderate NIDDM.


Supplements analyzed in this study

Holy Basil

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Insulin control


Slightly Positive
Holy Basil


Body systems related to this study


Endocrine System
Scroll to top